18-3089524-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003803.4(MYOM1):​c.4069+13C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.802 in 1,595,004 control chromosomes in the GnomAD database, including 514,139 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.82 ( 51010 hom., cov: 32)
Exomes 𝑓: 0.80 ( 463129 hom. )

Consequence

MYOM1
NM_003803.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0790

Publications

11 publications found
Variant links:
Genes affected
MYOM1 (HGNC:7613): (myomesin 1) The giant protein titin, together with its associated proteins, interconnects the major structure of sarcomeres, the M bands and Z discs. The C-terminal end of the titin string extends into the M line, where it binds tightly to M-band constituents of apparent molecular masses of 190 kD (myomesin 1) and 165 kD (myomesin 2). This protein, myomesin 1, like myomesin 2, titin, and other myofibrillar proteins contains structural modules with strong homology to either fibronectin type III (motif I) or immunoglobulin C2 (motif II) domains. Myomesin 1 and myomesin 2 each have a unique N-terminal region followed by 12 modules of motif I or motif II, in the arrangement II-II-I-I-I-I-I-II-II-II-II-II. The two proteins share 50% sequence identity in this repeat-containing region. The head structure formed by these 2 proteins on one end of the titin string extends into the center of the M band. The integrating structure of the sarcomere arises from muscle-specific members of the superfamily of immunoglobulin-like proteins. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MYOM1 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 18-3089524-G-T is Benign according to our data. Variant chr18-3089524-G-T is described in ClinVar as Benign. ClinVar VariationId is 226821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.864 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYOM1NM_003803.4 linkc.4069+13C>A intron_variant Intron 28 of 37 ENST00000356443.9 NP_003794.3 P52179-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYOM1ENST00000356443.9 linkc.4069+13C>A intron_variant Intron 28 of 37 1 NM_003803.4 ENSP00000348821.4 P52179-1
MYOM1ENST00000261606.11 linkc.3781+13C>A intron_variant Intron 27 of 36 1 ENSP00000261606.7 P52179-2
MYOM1ENST00000581075.1 linkn.169+13C>A intron_variant Intron 2 of 7 5 ENSP00000462039.1 J3KRK2

Frequencies

GnomAD3 genomes
AF:
0.819
AC:
124467
AN:
152058
Hom.:
50955
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.832
Gnomad AMI
AF:
0.693
Gnomad AMR
AF:
0.876
Gnomad ASJ
AF:
0.840
Gnomad EAS
AF:
0.742
Gnomad SAS
AF:
0.755
Gnomad FIN
AF:
0.840
Gnomad MID
AF:
0.829
Gnomad NFE
AF:
0.805
Gnomad OTH
AF:
0.821
GnomAD2 exomes
AF:
0.812
AC:
195058
AN:
240184
AF XY:
0.807
show subpopulations
Gnomad AFR exome
AF:
0.835
Gnomad AMR exome
AF:
0.908
Gnomad ASJ exome
AF:
0.836
Gnomad EAS exome
AF:
0.717
Gnomad FIN exome
AF:
0.834
Gnomad NFE exome
AF:
0.799
Gnomad OTH exome
AF:
0.821
GnomAD4 exome
AF:
0.800
AC:
1154821
AN:
1442828
Hom.:
463129
Cov.:
29
AF XY:
0.800
AC XY:
573775
AN XY:
717158
show subpopulations
African (AFR)
AF:
0.830
AC:
27525
AN:
33152
American (AMR)
AF:
0.904
AC:
39183
AN:
43340
Ashkenazi Jewish (ASJ)
AF:
0.836
AC:
21562
AN:
25792
East Asian (EAS)
AF:
0.752
AC:
29638
AN:
39388
South Asian (SAS)
AF:
0.775
AC:
63873
AN:
82380
European-Finnish (FIN)
AF:
0.834
AC:
42955
AN:
51484
Middle Eastern (MID)
AF:
0.822
AC:
4681
AN:
5694
European-Non Finnish (NFE)
AF:
0.796
AC:
877393
AN:
1101974
Other (OTH)
AF:
0.805
AC:
48011
AN:
59624
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
9735
19470
29206
38941
48676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20650
41300
61950
82600
103250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.819
AC:
124584
AN:
152176
Hom.:
51010
Cov.:
32
AF XY:
0.821
AC XY:
61040
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.832
AC:
34546
AN:
41504
American (AMR)
AF:
0.876
AC:
13390
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.840
AC:
2915
AN:
3472
East Asian (EAS)
AF:
0.742
AC:
3853
AN:
5190
South Asian (SAS)
AF:
0.756
AC:
3648
AN:
4824
European-Finnish (FIN)
AF:
0.840
AC:
8890
AN:
10588
Middle Eastern (MID)
AF:
0.827
AC:
243
AN:
294
European-Non Finnish (NFE)
AF:
0.805
AC:
54735
AN:
68008
Other (OTH)
AF:
0.824
AC:
1733
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1209
2417
3626
4834
6043
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.806
Hom.:
202531
Bravo
AF:
0.820
Asia WGS
AF:
0.770
AC:
2677
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

4069+13C>A in intron 28 of MYOM1: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus seq uence. It has been identified in 20.3% (1647/8114) of European American chromoso mes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs .washington.edu/EVS; dbSNP rs948298). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hypertrophic cardiomyopathy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
6.5
DANN
Benign
0.24
PhyloP100
0.079
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs948298; hg19: chr18-3089522; COSMIC: COSV55292367; COSMIC: COSV55292367; API